ZA879420B - 5-aryl-3h-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders - Google Patents

5-aryl-3h-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders

Info

Publication number
ZA879420B
ZA879420B ZA879420A ZA879420A ZA879420B ZA 879420 B ZA879420 B ZA 879420B ZA 879420 A ZA879420 A ZA 879420A ZA 879420 A ZA879420 A ZA 879420A ZA 879420 B ZA879420 B ZA 879420B
Authority
ZA
South Africa
Prior art keywords
triazol
aryl
ones
treatment
neurodegenerative disorders
Prior art date
Application number
ZA879420A
Inventor
Francis P Miller
P Miller Francis
Stephen Sorensen
Sorensen Stephen
John M Kane
M Kane John
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of ZA879420B publication Critical patent/ZA879420B/en

Links

ZA879420A 1987-10-16 1987-12-15 5-aryl-3h-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders ZA879420B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10700187A 1987-10-16 1987-10-16

Publications (1)

Publication Number Publication Date
ZA879420B true ZA879420B (en) 1988-07-27

Family

ID=22314340

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA879420A ZA879420B (en) 1987-10-16 1987-12-15 5-aryl-3h-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders

Country Status (2)

Country Link
PH (1) PH25733A (en)
ZA (1) ZA879420B (en)

Also Published As

Publication number Publication date
PH25733A (en) 1991-10-18

Similar Documents

Publication Publication Date Title
ZA804180B (en) Medicaments for the treatment of disorders in lipometabolism and their use
GB2207055B (en) Apparatus for use in the treatment of spinal disorders
HUP0100069A3 (en) 4(3)substituted-4(3)-aminomethyl-pyran, or -thiopyran-piperidine derivatives, their preparation and their use in the treatment of neurological disorders
EP0205579A4 (en) Methods and compositions useful in the diagnosis and treatment of autoimmune diseases.
EP0243968A3 (en) Diacetylrhein salts and their therapeutical use in the treatment of arthritis
EP0304802A3 (en) Pharmaceutical composition and the use thereof
EP0275668A3 (en) Use of ketone derivatives in the treatment of cognitive disorders
GB8908831D0 (en) Treatment of inflammatory disorders in humans
EP0432856A3 (en) Use of rolipram in the treatment of dementia
GB2200623B (en) Synthetic stevensite and it's preparation.
PH25019A (en) New benzamides and their use in treating gastrointestinal disorders
EP0450757A3 (en) Use of 5-hydroxytryptamine-antagonists in the treatment of mental disorders originating in childhood
ZA913497B (en) Azabenzimidazoles in the treatment of asthma,arthritis and related diseases
EP0488107A3 (en) Tricyclic benzodiazole analogs and their use in the treatment of cardiovascular disorders
GB2203645B (en) Improvements in the treatment of hair
EP0271127A3 (en) Use of guaifenesin in the treatment of urologic disorders
EP0427427A3 (en) Use of arylalkylamides in the treatment of neurodegenerative diseases
EP0215200A3 (en) Use of sulfanilamido quinoxalines in the treatment of neoplastic diseases
AU4096789A (en) The use of lactam derivatives in the treatment of cognitive disorders
ZA879420B (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use in the treatment of neurodegenerative disorders
GB2275191B (en) Use of antifungal compounds in the treatment of skin disorders
SG47098A1 (en) Diamines in the treatment of arrhythmia
GB8715914D0 (en) Treatment of cerabral disorders
AU641157B2 (en) 2-imino-thiadiazoline-5-sulphonamides and their use in the treatment of glaucoma
AU2153092A (en) Spirofurane derivatives and their use in the treatment of neurological disorders